Curis (CRIS) Interest Coverage Ratio Growth (3y) (2016 - 2025)
Curis (CRIS) Interest Coverage Ratio Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
129.54% |
| Sep 30, 2025 |
14.05% |
| Jun 30, 2025 |
-9.53% |
| Mar 31, 2025 |
-8.69% |
| Dec 31, 2024 |
2.39% |
| Sep 30, 2024 |
111.13% |
| Jun 30, 2024 |
452.69% |
| Mar 31, 2024 |
185.65% |
| Dec 31, 2023 |
-138.81% |
| Sep 30, 2023 |
-75.11% |
| Jun 30, 2023 |
-65.08% |
| Mar 31, 2023 |
-44.97% |
| Dec 31, 2022 |
-40.19% |
| Sep 30, 2022 |
-44.49% |
| Mar 31, 2022 |
-26.82% |
| Dec 31, 2021 |
-27.36% |
| Mar 31, 2021 |
8.10% |
| Dec 31, 2020 |
8.58% |
| Mar 31, 2020 |
64.51% |
| Dec 31, 2019 |
48.59% |
